4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow telavancin: new trials by email Literature Review of telavancin trials Research Report on telavancin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients Telavancin - Infection, Bacteremia | Phase 2 | Completed | M.D. Anderson Cancer Center | 40 | 2011-03-01 | 2019-12-27 |
| Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) Telavancin, vancomycin or antistaphylococcal penicillin - Infections, Gram-positive Bacterial | Phase 2 | Completed | Cumberland Pharmaceuticals | 201 | 2004-02-01 | 2019-01-16 |
| Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia Telavancin, Vancomycin, nafcillin, oxacillin, or cloxacillin - Gram-Positive Bacterial Infections | Phase 2 | Completed | Cumberland Pharmaceuticals | 60 | 2003-08-01 | 2019-01-16 |
| Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) Telavancin, Vancomycin or antistaphylococcal penicillin - Infections, Gram-Positive Bacterial, Abscess | Phase 2 | Completed | Cumberland Pharmaceuticals | 169 | 2003-06-01 | 2019-01-16 |
Gram-Positive Bacterial Infections (3) · Abscess (2) · Burns (2) · Cellulitis (2) · Ulcer (2) · Wound Infection (2) · Bacteremia (1) · Infections (1) · Sepsis (1) · Staphylococcal Infections (1)
Cumberland Pharmaceuticals (3) · M.D. Anderson Cancer Center (1)
United States (4)
G. Ralph Corey, MD (3) · Issam Raad, MD (1)